NO985242L - Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer - Google Patents

Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer

Info

Publication number
NO985242L
NO985242L NO985242A NO985242A NO985242L NO 985242 L NO985242 L NO 985242L NO 985242 A NO985242 A NO 985242A NO 985242 A NO985242 A NO 985242A NO 985242 L NO985242 L NO 985242L
Authority
NO
Norway
Prior art keywords
alkyl
optionally substituted
group
zero
ring
Prior art date
Application number
NO985242A
Other languages
English (en)
Norwegian (no)
Other versions
NO985242D0 (no
Inventor
Geoffrey Stemp
Amanda Johns
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609888.4A external-priority patent/GB9609888D0/en
Priority claimed from GBGB9617189.7A external-priority patent/GB9617189D0/en
Priority claimed from GBGB9704490.3A external-priority patent/GB9704490D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO985242D0 publication Critical patent/NO985242D0/no
Publication of NO985242L publication Critical patent/NO985242L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO985242A 1996-05-11 1998-11-10 Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer NO985242L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9609888.4A GB9609888D0 (en) 1996-05-11 1996-05-11 Compounds
GBGB9617189.7A GB9617189D0 (en) 1996-08-16 1996-08-16 Compounds
GBGB9704490.3A GB9704490D0 (en) 1997-03-05 1997-03-05 Compounds
PCT/EP1997/002434 WO1997043262A1 (en) 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors

Publications (2)

Publication Number Publication Date
NO985242D0 NO985242D0 (no) 1998-11-10
NO985242L true NO985242L (no) 1998-12-09

Family

ID=27268278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985242A NO985242L (no) 1996-05-11 1998-11-10 Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer

Country Status (18)

Country Link
US (1) US6046210A (de)
EP (1) EP0917530B1 (de)
JP (1) JP2000510137A (de)
KR (1) KR20000010905A (de)
AR (1) AR007077A1 (de)
AT (1) ATE232850T1 (de)
AU (1) AU2897497A (de)
BR (1) BR9709220A (de)
CA (1) CA2253927A1 (de)
CZ (1) CZ363298A3 (de)
DE (1) DE69719191T2 (de)
ES (1) ES2191838T3 (de)
IL (1) IL126747A0 (de)
NO (1) NO985242L (de)
NZ (1) NZ332477A (de)
PL (1) PL329803A1 (de)
TR (1) TR199802284T2 (de)
WO (1) WO1997043262A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263284A1 (en) * 1996-08-14 1998-02-19 Smithkline Beecham P.L.C. Tetrahydroisoquinoline derivatives and their pharmaceutical use
GB9708694D0 (en) * 1997-04-30 1997-06-18 Smithkline Beecham Plc Compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
BR9809591A (pt) * 1997-05-03 2001-09-11 Smithkline Beecham Plc Derivados de tetraidoisoquinolina como moduladores de receptores de dopamina d3
GB9709303D0 (en) * 1997-05-09 1997-06-25 Smithkline Beecham Plc Compounds
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
GB9812522D0 (en) * 1998-06-10 1998-08-05 Smithkline Beecham Plc Compounds
GB9821978D0 (en) 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
WO2000021951A1 (en) * 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
GB9821977D0 (en) * 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
AU2003245773A1 (en) 2002-02-15 2003-09-04 Glaxo Group Limited Vanilloid receptor modulators
AR040126A1 (es) 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
WO2005048810A2 (en) * 2003-07-31 2005-06-02 Washington University In St. Louis Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
US7659400B2 (en) * 2003-07-31 2010-02-09 Washington University Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
KR20070047763A (ko) * 2004-07-20 2007-05-07 시에나 바이오테크 에스.피.에이. 알파7 니코틴성 아세틸콜린 수용체의 조절제 및 그의치료적 용도
US20060235028A1 (en) * 2005-04-14 2006-10-19 Li James J Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
CN102264733B (zh) 2008-10-10 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 新型多巴胺d3受体配体,其制备方法及其医药用途
WO2016034673A1 (en) 2014-09-03 2016-03-10 Ctxt Pty Ltd Tetrahydroisoquinoline derived prmt5-inhibitors
EP3189048B1 (de) 2014-09-03 2021-03-17 Ctxt Pty Ltd Vom aminoindan, aminotetrahydronaphthalen und aminobenzocyclobutan abgeleitete prmt5-inhibitoren
GB201415573D0 (en) 2014-09-03 2014-10-15 Cancer Therapeutics Crc Pty Ltd Compounds
GB201604020D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604030D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604031D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604022D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604027D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604029D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
CA3089498A1 (en) 2018-01-26 2019-08-01 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
PL329803A1 (en) 1999-04-12
CZ363298A3 (cs) 1999-06-16
EP0917530B1 (de) 2003-02-19
DE69719191D1 (de) 2003-03-27
JP2000510137A (ja) 2000-08-08
NO985242D0 (no) 1998-11-10
ATE232850T1 (de) 2003-03-15
TR199802284T2 (xx) 2000-05-22
BR9709220A (pt) 1999-08-10
AU2897497A (en) 1997-12-05
NZ332477A (en) 2000-07-28
DE69719191T2 (de) 2003-11-27
CA2253927A1 (en) 1997-11-20
IL126747A0 (en) 1999-08-17
US6046210A (en) 2000-04-04
AR007077A1 (es) 1999-10-13
WO1997043262A1 (en) 1997-11-20
ES2191838T3 (es) 2003-09-16
KR20000010905A (ko) 2000-02-25
EP0917530A1 (de) 1999-05-26

Similar Documents

Publication Publication Date Title
NO985242L (no) Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer
NO995338L (no) Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer
NO941101L (no) Quinazolin-derivater
DE69613860D1 (de) Pyrazol-derivate, verfahren für ihre herstellung und sie enthaltende zusammensetzungen
ATE454375T1 (de) 1-phenyl-benzimidazolverbindungen und ihre verwendung als modulatoren des gaba-a-rezeptors
NZ327052A (en) Novel substituted imidazole compounds
NO982913L (no) Kinolin- og kinazolinforbindelser nyttige i terapi
DE69021502D1 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und Anwendung.
EA200100428A1 (ru) Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
ATE293101T1 (de) Piperidine zur verwendung als orexin rezeptor antagonisten
ZA200400070B (en) Ortho-substituted aryl amides for controlling invertebrate pests
NO20060219L (no) Forbindelser
DE69510033D1 (de) Aryl- und heteroaryl- pyrimidine als herbizide
YU44998A (sh) Pirazolska jedinjenja, postupci za njihovu proizvodnju i herbicidi koji ih sadrže
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
ATE312830T1 (de) 2,3-dihydro-1h-isoindol-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
DE69310904D1 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
ATE34978T1 (de) Imidazolinon-derivate als histamin-h2antagonisten.
ES2079315A1 (es) Nuevas imidazopiridinas.
ATE235822T1 (de) Verwendung von sulfonyloxadiazolonen als mikrobizide
ES2186365T3 (es) Derivados de tetrahidroisoquinolina como moduladores de los receptores d3 de la dopamina.
DE69836427D1 (de) Heterozyclische ketonen als npy y5 antagonisten
YU48255B (sh) Racemski ili optički aktivni izohinolin derivati, postupak za njihovo dobivanje i postupak za dobivanje farmaceutskih preparata koji ih sadrže
DK0516486T3 (da) Azetidinonderivater egnede til fremstilling af carbapenemantibiotika
MX9804482A (es) Quinolinas y quinazolinas utiles en terapias.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application